Delivery Order SPE2DR25D2206-SPE2DR26F9MT2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical procedures. This firm fixed-price delivery order, valued at $4,839.49, represents a competitive award with no set-aside designation and is scheduled for completion by August 22, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $12,706.89 to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical applications. This competitively awarded, firm fixed-price contract was issued on July 29, 2025, with an ultimate completion date of July 30, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed...
- The Defense Logistics Agency awarded a $1,094.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical settings. The award, issued on December 19, 2025, with an ultimate completion date of December 22, 2025, represents a non-competitive, non-set-aside order. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and serves as a critical vendor...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical applications. This competitively awarded, firm fixed-price delivery order, valued at $20,512.70, was issued on December 9, 2025, with an ultimate completion date of December 10, 2025. The contract utilizes no set-aside designation, indicating that AmerisourceBergen competed against other qualified vendors to secure the...
- The Defense Logistics Agency awarded a delivery order valued at $2,746.32 to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical applications. This competitively awarded, firm fixed-price delivery order was issued on December 19, 2025, with an ultimate completion date of December 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical applications. This firm fixed-price delivery order, valued at $11,306.34, was competitively awarded with an ultimate completion date of December 17, 2025. The award represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical applications. This competitively awarded, firm fixed-price delivery order, valued at $5,912.18, was issued on December 22, 2025, with an ultimate completion date of December 23, 2025. The order is being fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $18,783.90 firm fixed price delivery order for 20,000 units of RECOTHROM, a thrombin-based hemostatic agent used in surgical settings to control bleeding. This non-set-aside competitive award was issued on December 11, 2025, with an ultimate completion date of January 9, 2026, and will be performed at the contractor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical applications. This firm fixed-price delivery order, valued at $1,793.32, was competitively awarded without set-aside designation and is scheduled for completion by August 4, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical applications. This firm fixed-price delivery order, valued at $25,119.14, was competitively awarded without set-aside designation and is scheduled for completion by September 9, 2025. The product will be delivered to AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania, where the company maintains its...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9MT2Delivery Order
On January 23, 2026, the Defense Logistics Agency awarded a delivery order valued at $33,704.33 to Amerisourcebergen Drug Corp for 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical settings. This competitive, firm fixed-price contract is scheduled for completion by January 26, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating full and open competition among eligible vendors. This delivery order is executed under Amerisourcebergen Drug Corp's parent company, Cencora, Inc. (doing business as Amerisourcebergen), which holds a significant Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical valued at up to $999,999,999.00 through December 2031. This prime vehicle provides comprehensive pharmaceutical and medical supply support for military healthcare programs globally, enabling the rapid fulfillment of critical medical commodities including specialty medications, vaccines, and related medical products across multiple therapeutic domains to support Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $33.7k | 1/22/26 |